相关实验视频

Updated: May 28, 2025

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

利科哈尔科恩A可以防止皮脂多糖诱导的神经炎症小鼠模型的认知衰退

Marina Carrasco^1,2,3,4, Laura Guzman^1,2,3, Jordi Olloquequi^5,6

¹Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.

Molecular medicine (Cambridge, Mass.)

|February 10, 2025

概括

利科哈尔康A (LCA) 预防由炎症引起的认知衰退和抑郁症. 这种神经保护作用是通过减少炎症,增强抗氧化防御和改善突触功能来实现的.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

神经炎症是不可治愈的神经退行性疾病的关键因素.
利科哈尔A (LCA) 显示出潜在的抗炎和神经保护性质,但其机制尚未完全理解.

研究的目的:

调查LCA是否可以预防小鼠的脂聚糖 (LPS) 诱导的认知衰退.
阐明LCA的神经保护机制.

主要方法:

小鼠接受LCA或盐水治疗,随后进行LPS或盐水注射.
分析了基因表达,氧化应激标志物,代谢途径和突触蛋白.

主要成果:

LPS诱导认知障碍,类似抑郁症的行为,以及与氧化应激,新陈代谢和突触相关的基因表达的改变.
通过减少炎症 (化,M1/M2标志物),增强抗氧化机制 (酸盐合成酶,SOD2),改善代谢和突触功能 (GLUT4,P-AKT,P-CREB,BDNF,PSD95) 来抵消LPS的影响.

结论:

治疗LCA可以预防LPS诱导的认知衰退.
通过减少炎症,增强抗氧化反应,改善代谢功能和促进突触可塑性,LCA发挥神经保护作用.

关键词:

石灰是一种的材料.认知能力下降认知能力下降树状的棘树状的棘炎症炎症是一种炎症.甘露是一种甘.代谢过程中的代谢.神经退行发生神经退行.氧化应激是一种氧化应激.

更多相关视频

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity

Published on: August 23, 2022

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.